T2 Biosystems Inc
Change company Symbol lookup
Select an option...
TTOO T2 Biosystems Inc
AMPE Ampio Pharmaceuticals Inc
IKNX Ikonics Corp
UTX United Technologies Corp
KR Kroger Co
$TBK.TC iSHR LEH TIPS TC
NFLX Netflix Inc
MLM Martin Marietta Materials Inc
HUBS HubSpot Inc
SBUX Starbucks Corp
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Closing Price
$0.60
Day's Change
-0.0495 (-7.62%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.6229
Day's Low
0.58
Volume
(Light)
Volume:
4,757,220

10-day average volume:
28,898,199
4,757,220

Display:

Providers:

UpdateCancel
7 providers
March 27, 2020
Thinking about buying stock in Aytu Bioscience, GameStop, Translate Bio, Tilray, or T2 Biosystems?

InvestorsObserver issues critical PriceWatch Alerts for AYTU, GME, TBIO, TLRY, and TTOO. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

March 24, 2020
T2 Biosystems Announces Worldwide Licensing Agreement of COVID-19, Novel Coronavirus Assay from Hackensack Meridian Health's Center for Discovery and Innovation

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it has entered into a worldwide licensing agreement for a rapid COVID-19, novel coronavirus test developed by the Center of...(Globe Newswire)

T2 Biosystems Announces Preliminary First Quarter 2020 Financial Results

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced unaudited, preliminary financial result estimates for the quarter ended March 31, 2020, and suspended full year 2020 financial and...(Globe Newswire)

March 19, 2020
T2 Biosystems Receives Multiyear Innovative Technology Contract from Vizient, Inc.

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it was awarded an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement...(Globe Newswire)

February 24, 2020
T2 Biosystems Announces Fourth Quarter and Full Year 2019 Financial Results

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter and Recent Business and Financial...(Globe Newswire)

February 19, 2020
T2 Biosystems to Participate in the SVB Leerink Global Healthcare Conference

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming SVB Leerink Global Healthcare Conference in New York, New York. (Globe Newswire)

February 12, 2020
T2 Biosystems to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2019 after market close on Monday, February 24, 2020. Company...(Globe Newswire)

February 04, 2020
T2 Biosystems Announces Participation at Clinical Conferences in February

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the Company's participation in two conferences in February: Society of Critical Care Medicine's (SCCM) 48th Critical Care Congress, and...(Globe Newswire)

January 17, 2020
T2 Biosystems Reports Granting of Inducement Award

T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it issued an inducement award to John Sperzel, the...(Globe Newswire)

January 13, 2020
T2 Biosystems Promotes Tony Pare to Chief Commercial Officer

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that its Chief Executive Officer (CEO), John Sperzel, has promoted Tony Pare to the newly...(Globe Newswire)

January 09, 2020
T2 Biosystems Announces Preliminary Fourth Quarter 2019 Financial Results

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced preliminary revenue and business results for the three months ended December 31, 2019. (Globe Newswire)

T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that its Board of Directors has appointed diagnostics industry veteran John Sperzel as...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.